Hadas Friedman

Hadas Friedman has extensive work experience in the field of quality assurance and regulatory affairs in the pharmaceutical industry. Hadas served as the VP QA/RA Clinical Affairs at Pharma Two B from December 2012 onwards, where they were responsible for overseeing phase 2 and phase 3 studies in the USA, EU, and Israel, as well as multiple PK studies. Hadas also handled IND and multiple IND amendments and participated in EOP2 and pre-NDA meetings.

Prior to that, Hadas worked at Intec Pharma Ltd. from 2004 to 2012, again as the VP QA/RA Clinical Affairs. In this role, they managed a phase 2 study in Israel and multiple studies in healthy volunteers. Hadas also submitted an IND and multiple IND amendments and participated in a pre-IND meeting.

From 2000 to 2004, Hadas served as the Quality Assurance Manager at Procognia, where they built and managed a quality assurance system for devices in an ISO environment, including software QA.

Before that, Hadas worked at Rafa Laboratories from 1993 to 2000, holding roles such as Medical Information and Regulatory Affairs and Quality Assurance Associate.

Overall, Hadas Friedman has gained significant expertise in quality assurance, regulatory affairs, and clinical studies throughout their career.

Hadas Friedman obtained their Master's degree in Molecular Biology from Bar-Ilan University, where they studied from 1986 to 1993.